P/E Ratio (TTM)
-13.51
ASCENTAGE PHARMA GROUP INTERNATIONAL currently has a P/E ratio of -13.51. The P/E ratio is a primary valuation multiple used to determine if a stock is overvalued or undervalued relative to its earnings.
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2016-06-30 | -6.93 |
| 2016-12-31 | -7.24 |
| 2017-06-30 | -102.28 |
| 2017-12-31 | -3.18 |
| 2018-06-30 | -26.57 |
| 2018-12-31 | -1.13 |
| 2019-06-30 | -0.53 |
| 2019-12-31 | -0.54 |
| 2020-06-30 | -1.22 |
| 2020-12-31 | -1.13 |
| 2021-06-30 | -1.14 |
| 2021-12-31 | -1.12 |
| 2022-06-30 | -1.09 |
| 2022-12-31 | -1.12 |
| 2023-06-30 | -1.38 |
| 2023-12-31 | -4.27 |
| 2024-06-30 | 14.35 |
| 2024-12-31 | -4.36 |
| 2025-06-30 | -10.19 |
Annual P/E
| Year | P/E Ratio |
|---|
* P/E ratios are calculated using trailing twelve-month (TTM) earnings. Extreme values may indicate earnings anomalies or cyclical volatility.